A field evaluation of a rapid dual immunoassay for human immunodeficiency virus and syphilis antibodies, Hanoi, Vietnam.


Journal

International journal of STD & AIDS
ISSN: 1758-1052
Titre abrégé: Int J STD AIDS
Pays: England
ID NLM: 9007917

Informations de publication

Date de publication:
02 2019
Historique:
pubmed: 24 10 2018
medline: 3 9 2019
entrez: 24 10 2018
Statut: ppublish

Résumé

The SD BIOLINE HIV/Syphilis Duo (SD BIOLINE DUO) rapid test is a dual rapid lateral flow immunoassay that detects antibodies to both human immunodeficiency virus (HIV) and Treponema pallidum (TP) 'syphilis' via fingerprick whole blood. We evaluated the field performance of the SD BIOLINE HIV/Syphilis Duo test among two populations in Hanoi, Vietnam - men who have sex with men (MSM) and pregnant women. We also surveyed factors that influence participants' willingness to test for HIV and syphilis. This test has the potential to increase HIV and syphilis screening in low-resource settings. Patients who received healthcare services at a sexual health clinic for MSM and a district antenatal care center in Hanoi, Vietnam were recruited for the study. Participants with HIV and syphilis were intentionally recruited for adequate test performance evaluation via convenience sampling. At each facility, venipuncture blood specimens were obtained for reference testing for HIV and TP using SD BIOLINE HIV 1/2 3.0 and TP particle agglutination, respectively. SD BIOLINE DUO was compared to the standard reference tests and sensitivity and specificity were calculated. We calculated 95% confidence interval (CI) using the exact binomial method. We used conjoint analysis to identify test attributes that are associated with participant likelihood to seek HIV and syphilis testing. Of 280 participants, 100 (35.7%) were MSM and 180 (64.3%) were pregnant women. Of MSM, 17 (17.0%) were HIV positive and 49 (49.0%) were TP seropositive. All women were negative for both HIV and syphilis antibodies. For HIV antibody testing, sensitivity and specificity were 100.0% (95% CI: 80.5-100.0%) and 100.0% (95% CI: 98.6-100.0%), respectively. For the syphilis antibody testing, sensitivity and specificity were 83.1% (95% CI: 71.0-91.6%) and 100.0% (95% CI: 98.3-100.0%), respectively. Potential for false positives, preference for one blood draw over two, and shorter wait time for testing results were the highest ranked attributes by participants according to their willingness to test. The SD BIOLINE HIV/Syphilis Duo rapid test demonstrated very good performance in this field setting and participants preferred attributes that aligned well with this test.

Identifiants

pubmed: 30348065
doi: 10.1177/0956462418802685
pmc: PMC7439759
mid: NIHMS1046991
doi:

Substances chimiques

Antibodies, Bacterial 0
Antibodies, Viral 0

Types de publication

Evaluation Study Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

173-180

Subventions

Organisme : NIAID NIH HHS
ID : P30 AI028697
Pays : United States
Organisme : NIMH NIH HHS
ID : P30 MH058107
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI139265
Pays : United States

Références

AIDS Care. 2008 Jul;20(6):654-9
pubmed: 18576166
Sex Transm Infect. 2016 Nov;92(7):495-498
pubmed: 27154184
J Int AIDS Soc. 2016 Oct 21;19(1):20965
pubmed: 27774955
Int J Gynaecol Obstet. 2015 Jun;130 Suppl 1:S15-21
pubmed: 26001704
Med Mal Infect. 2014 Dec;44(11-12):525-9
pubmed: 25391806
Int J STD AIDS. 2017 Mar;28(3):259-264
pubmed: 27037111
Open Forum Infect Dis. 2014 May 27;1(1):ofu015
pubmed: 25734088
BMC Public Health. 2008 Jan 28;8:37
pubmed: 18221565
Int J Gynaecol Obstet. 2015 Jun;130 Suppl 1:S22-6
pubmed: 25975869
LGBT Health. 2015 Dec;2(4):341-5
pubmed: 26788775
Sex Transm Infect. 2017 Dec;93(S4):S3-S15
pubmed: 28747410
Sex Transm Infect. 2016 May;92(3):182-5
pubmed: 26670914
BMC Public Health. 2013 Dec 28;13:1236
pubmed: 24373483
PLoS Med. 2013;10(2):e1001396
pubmed: 23468598

Auteurs

Keenan Withers (K)

1 David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.

Clare Bristow (C)

2 Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, La Jolla, CA, USA.

Minh Nguyen (M)

3 Center for Research and Training of AIDS, Hanoi Medical University, Hanoi, Vietnam.

Chrysovalantis Stafylis (C)

4 Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.

Le M Giang (LM)

3 Center for Research and Training of AIDS, Hanoi Medical University, Hanoi, Vietnam.

Jeffrey D Klausner (JD)

1 David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
4 Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH